EGFR-TKIs耐药与EGFR突变非小细胞肺癌中PD-L1表达的研究进展Research Progress of EGFR-TKIs Resistance and PD-L1 Expression in EGFR-Mutant Non-Small Cell Lung Cancer
温雅婷, 高俊珍
临床医学进展Vol.14 No.1, 全文下载: PDF HTML XML DOI:10.12677/ACM.2024.141027, January 8 2024
肺腺癌脑转移患者EGFR-TKI耐药后治疗的文献综述A Literature Review on the Treatment of Patients with Brain Metastasis from Lung Adenocarcinoma after EGFR-TKI Resistance
刘雨欣, 李长毅
临床医学进展Vol.15 No.4, 全文下载: PDF XML DOI:10.12677/acm.2025.1541291, April 28 2025
EGFR变构抑制剂在小细胞肺癌治疗中的作用和未来发展The Role and Future Development of EGFR Allosteric Inhibitors in the Treatment of Small Cell Lung Cancer
贾硕磊, 周庆发
药物化学Vol.12 No.3, 全文下载: PDF XML DOI:10.12677/hjmce.2024.123021, July 30 2024
晚期肺腺癌患者获得性EGFR-TKI耐药后治疗的研究进展Research Progress of Acquired EGFR-TKI Resistance in Patients with Advanced Lung Adenocarcinoma
王 康, 胡雪婷, 罗 虎, 周向东 科研立项经费支持
临床医学进展Vol.11 No.9, 全文下载: PDF HTML XML DOI:10.12677/ACM.2021.119578, September 10 2021
EGFR T790M位点突变型非小细胞肺癌耐药机制及耐药后的综合治疗EGFR T790M Site-Mutated Non-Small Cell Lung Cancer Drug Resistance Mechanism and Comprehensive Treatment after Drug Resistance
武卉淇, 马金华
临床医学进展Vol.12 No.7, 全文下载: PDF HTML XML DOI:10.12677/ACM.2022.127991, July 22 2022
EGFR突变的非小细胞肺癌脑转移患者的靶向药物选择Targeted Drug Selection in Non-Small Cell Lung Cancer Patients with EGFR Mutation-Induced Brain Metastases
杨宗辉, 山凤连 科研立项经费支持
临床个性化医学Vol.4 No.2, 全文下载: PDF XML DOI:10.12677/jcpm.2025.42180, March 31 2025